What is the first‑line treatment for an intertriginous rash under a large abdominal pannus?

First-Line Treatment for Intertriginous Rash Under Pannus

For an intertriginous rash under a large abdominal pannus, topical azole antifungals (clotrimazole, miconazole, or ketoconazole 2%) applied twice daily combined with aggressive moisture control measures are the first-line treatment. 1, 2, 3

Initial Approach: Determine the Etiology

The most common cause of intertriginous rash under a pannus is candidal intertrigo, which presents with:

• Erythematous, macerated skin with satellite pustules (key diagnostic feature) 3
• Moisture-related changes in skin folds 2

If satellite pustules are absent and you see well-demarcated plaques, consider inverse psoriasis instead, which requires different treatment 3

First-Line Pharmacologic Treatment

For Candidal Intertrigo (Most Common)

Topical azole antifungals are the cornerstone:

• Apply ketoconazole 2% cream, clotrimazole cream, or miconazole cream twice daily to affected areas 1, 2, 3
• Alternative: Nystatin cream or powder provides equally effective polyene therapy 1, 2
• Expected response: 5-10% of patients experience mild local burning sensation 3

Critical adjunctive measure (as important as medication):

• Keep the area completely dry between applications—this is as essential as the antifungal itself for treatment success 1, 2
• Use absorptive powders (cornstarch) or barrier creams 4
• Patients should wear light, nonconstricting, absorbent clothing and avoid wool/synthetic fibers 4

For Inverse Psoriasis (If No Satellite Pustules Present)

Use steroid-sparing agents for intertriginous areas:

• Tacrolimus 0.1% ointment applied to affected areas—65% of patients achieve clear or almost clear skin after 8 weeks 5, 2
• Alternative: Pimecrolimus cream for 4-8 weeks 5, 2
• Low-potency topical corticosteroids may be used short-term, but avoid high-potency agents due to increased atrophy risk in skin folds 5, 2

Critical pitfall: High-potency corticosteroids like clobetasol 0.05% are contraindicated as monotherapy for fungal infections—they suppress local immunity and worsen candidiasis 3

When to Escalate to Systemic Therapy

Reserve oral fluconazole for specific situations only:

• Dose: 100-200 mg daily for 7-14 days (or single 150 mg dose for severe cases) 1, 2, 3
• Indications: Extensive disease, treatment failure after 7-10 days of adequate topical therapy, or resistant cases 1, 2, 3
• Important caveat: Fluconazole carries drug-drug interaction risks (warfarin, calcium-channel blockers, oral hypoglycemics, phenytoin) and rare hepatotoxicity 3

Do NOT use terbinafine—it has no activity against Candida and is only for dermatophyte infections 3

Address Predisposing Factors

To prevent recurrence, you must manage underlying conditions:

• Obesity, diabetes mellitus, immunosuppression all facilitate disease occurrence and recurrence 2, 6
• Counsel patients on heat/humidity precautions and proper hygiene after physical activity 4
• For recurrent cases, consider maintenance therapy with intermittent topical antifungals 2

Treatment Algorithm Summary

1. Examine for satellite pustules to differentiate candidal intertrigo from inverse psoriasis 3
2. If candidal (satellite pustules present): Topical azole twice daily + aggressive moisture control 1, 2, 3
3. If inverse psoriasis (no pustules): Tacrolimus 0.1% or pimecrolimus, avoid high-potency steroids 5, 2
4. If no improvement after 7-10 days: Consider oral fluconazole 100-200 mg daily 1, 2
5. Always address: Weight management, diabetes control, moisture reduction strategies 2, 6

Common pitfall to avoid: Do not routinely combine antibacterial agents with antifungals unless clear evidence of bacterial superinfection exists—Candida is rarely found in psoriatic intertriginous areas, and unnecessary antimicrobial combinations should be avoided 7